Opko

NEW YORK (GenomeWeb News) – Opko Health has received a $1 million grant from the Bill and Melinda Gates Foundation for the development of a tuberculosis test, the company announced today.

Opko Health has entered a definitive agreement to acquire Prost-Data, which does business as OURLab, a Nashville, Tenn.-based CLIA laboratory.

With Marina Biotech's back against the wall, the RNAi drugs field may soon see the departure of its third player this year, following the bankruptcy of Traversa Therapeutics and the acquisition of Tacere Therapeutics by Benitec Biopharma.

Title: Natural Antisense and Non-Coding RNA Transcripts as Drug Targets
Patent Number: 8,288,354
Filed: Dec. 28, 2006

Opko Health said this week that its partner International Heath Technology has begun selling its Opko 4kscore prostate cancer test in Europe as part of IHT's ProstateCheck program.

Opko Health last week presented data at the Alzheimer's Association International Conference in Vancouver demonstrating that its antibody-based Alzheimer's diagnostic identified cases of the disease with 100 percent specificity in a set of 36 autopsy-confirmed plasma samples.

Title: Enhancement of Influenza Gene Expression
Patent Number: 8,227,188
Filed: Sept. 3, 2010
Lead Inventor: Antonin de Fougerolles, Alnylam Pharmaceuticals

Quanterix announced this week it has appointed Paul Chapman as its new president and CEO, replacing Martin Madaus, who will continue at the company as executive chairman.

Opko Health has named Juan Rodriguez as its new senior vice president and chief financial officer.
Rodriguez replaces Rao Uppaluri, who is retiring from the company.

NEW YORK (GenomeWeb News) – Opko Health today announced it has granted UK-based International Health Technology the rights to offer a novel panel of protein biomarkers and an associated algorithm in parts of Europe for the detection of prostate cancer.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.